“…Most existing studies investigate the impact of cluster A PD on treatment effects of axis I treatments or focus on the effectiveness of psychopharmacological treatment of schizotypal PD. It has been shown in these studies that the presence of cluster A PD, especially schizotypal PD, has a negative influence on the outcome of axis I treatments of both medical and psychotherapeutic kind [15,16,17,18,19]. Medication studies of schizotypal PD have shown that typical and atypical antipsychotics, and possibly antidepressants, can have a positive influence on distinguished symptoms , such as cognitive disturbance, derealisation, ideas of reference, anxiety, self-image, social and overall functioning, odd communication, obsessive-compulsive symptoms and self-injury [20,21,22,23,24,25,26,27,28,29].…”